She earned her PhD in Oncological Sciences at the University of Utah where she studied the role of the retinoic acid response pathway in colon carcinogenesis. She completed her postdoctoral research at the Dana-Farber Cancer Institute/Harvard Medical School in Boston where she studied mitochondrial apoptosis and the DNA damage response pathway using zebrafish as a genetic model system. The primary interest of the Jette Lab has been the identification and analysis of novel radioprotective genes using genetics and cell biological approaches in zebrafish and human cell culture. The ultimate goal is to identify new therapeutic targets for the treatment of apoptosis-resistant human cancers.